D-0713-2026 Class III Ongoing

Recalled by Asclemed USA Inc. — Torrance, CA

FDA drug recall D-0713-2026 was initiated by Asclemed USA Inc. on Jul 15, 2026 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan The recall status is ongoing. Affected quantity: 18 kits.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 15, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18 kits

Product description

Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.

Reason for recall

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Distribution pattern

Within U.S. - Tennessee

Code information

Lot: 070126X1, Exp. 12/31/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0713-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0713-2026. Report a data issue: hello@regdatalab.com.